CDKN2A and peripheral neuropathy: This result is in line with previous findings that clearance of senescent-like neuronal cells in DRG, through a senolytic (ABT263) intervention and p16-3MR transgenic mouse model, reduced mechanical and thermal hyperalgesia in a mouse model of cisplatin-induced peripheral neuropathy [44].